A new update from the Shift-OUT study molnupiravir showed a relative risk reduction of 30% for hospitalization or death, as well as relative risk reduction Loss of life was 89%, when molnupiravir compared to placebo. Moreover protecting by yourself and those in All your family members, social distancing and carrying https://georgem764eii2.glifeblog.com/27519265/the-definitive-guide-to-clazosentan